Brief: Erytech Announces That The Commercial Court Has Rejected Akkadian's Request To Postpone The Vote On The Merger With Pherecydes Pharma

Phaxiam Therapeutics SA

14/06/2023 19:03

June 14 (Reuters) - Pherecydes Pharma SA  ALPHE.PA :
    * REG-ERYTECH ANNOUNCES THAT THE COMMERCIAL COURT HAS
REJECTED
AKKADIAN'S REQUEST TO POSTPONE THE VOTE ON THE MERGER WITH
PHERECYDES PHARMA
    * ERYTECH PHARMA SA - ERYTECH SHAREHOLDERS WILL BE ABLE TO
LEGITIMATELY VOTE ON MERGER ON JUNE 23, 2023
    * ERYTECH PHARMA SA - EXPERT HAS BEEN APPOINTED TO EXAMINE
MERGER
PARITY AND MUST SUBMIT HIS REPORT TO PARTIES WITHIN 4 MONTHS
    * ERYTECH PHARMA SA - AKKADIAN PARTNERS HAS TO COVER COSTS
OF THIS
EXPERT APPRAISAL
    * ERYTECH PHARMA SA - AKKADIAN PARTNERS HAS ALSO BEEN
ORDERED TO
INDEMNIFY ERYTECH FOR COSTS INCURRED BY COMPANY IN THIS
PROCEDURE

Source text for Eikon:  ID:nGNE898XKt 
Further company coverage:  ALPHE.PA 

 ((Reuters.Briefs@thomsonreuters.com;))